The China National Biotec Group (CNBG) on Thursday said in a statement posted on Chinese social media platform WeChat that they have successfully prepared special immune plasma products, and will use them in the clinical treatment of severe coronavirus patients.
More than 10 severe coronavirus patients have received the plasma therapy at a hospital in Wuhan since Feb 8. Within 12 to 24 hours of the therapy, patients have seen a decline in indicators of inflammation and a hike in lymphocytes, among other favorable turns.
Shen Yinzhong, director of the medical department at Shanghai Public Health Clinical Center, said that cured patients have to meet certain criteria before donating plasma. "First, donors must be in good health… we won't collect their plasma forcefully," Shen said. "They must donate voluntarily."